Login

Healthcare

00:10:00
Developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products|Klaus Paulini,CEO,AEterna Zentaris Inc
00:10:00
Allosteric modulators for Human Health|TIM DYER,CEO,Addex Therapeutics Ltd
00:10:00
Developing innovative solutions to debilitating diseases|Tim Oldham PhD,CEO,Adalta Ltd
00:10:00
Cognitive functions include episodic and working memory attention problem solving and language|Dr Steven Gourlay,CEO,Actinogen Medical Ltd
00:10:00
Analytical tools and techniques to reverse engineer and characterise the composition of reference products|Michael Kotsanis,CEO,Acrux Ltd
00:10:00
A NEW SOLUTION TO QUIT SMOKING|John Bencich,Chief Executive Officer,Achieve Life Sciences Inc
00:10:00
Biotech CEO discusses advancements in Alzheimer's and psychiatric disorder treatments, highlighting promising clinical results and future prospects |Stephan Jackman, CEO, Alzamend Neuro Inc.
00:10:00
Alvotech's Integrated Approach and Expansive Pipeline Energize Pharmaceutical Markets Worldwide|Róbert Wessman, CEO, Alvotech SA.
00:10:00
Navigating the landscape of medical cannabis opportunities and risks with insights from industry experts |Josh Fegan, CEO,Althea Group.
00:10:00
CEO Discusses Strategic Vision for Environmental, Social, and Governance Initiatives|Gianfranco Nazzi, CEO, Almirall SA.
00:10:00
Exploring Agios' Pioneering Approach at the Intersection of Cancer Metabolism and Genomics | David Schenkein, CEO,Agios Pharmaceuticals Inc .
00:10:00
Exploring Innovations in Cancer Immunotherapy|Søren Bregenholt, CEO, Alligator Bioscience AB.
00:10:00
Akari Therapeutics' Innovative Approach to Treating Rare Hematopoietic Stem Cell Transplant Complications| Rachelle Jacques, CEO, Akari Therapeutics PLC.
00:10:00
Navigating Forward-Looking Statements and Risks in AIM ImmunoTech's Interview| Thomas Equels, CEO, AIM ImmunoTech Inc.
00:10:00
Unlocking the Secrets of Human Aging: The Role of Telomeres and Telomerase |Dr. Michael D. West , CEO, AgeX Therapeutics Inc .
00:10:00
Analyzing Allergy Therapeutics' Financial Performance and Promising Developments Amid Record Pre-R&D Operating Profit and Successful Biomarker Study |Manuel Llobet, CEO, Allergy Therapeutics PLC.

© 2026 Nehu